))
Labeling Change, Life-Saving Impact. The FDA’s New Opioid Rules
Manage episode 512676562 series 3347948
Content provided by Womble Bond Dickinson. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Womble Bond Dickinson or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
On July 31st, 2025, the U.S. Food and Drug Administration announced sweeping changes to the safety labeling of all opioid pain medications. These updates aim to better communicate the risks of long-term opioid use—risks that include misuse, addiction, overdose, and a range of serious side effects.
For drug manufacturers, this means updating product labels to help patients, doctors, pharmacists, and other healthcare providers make more informed decisions. But the implications go far beyond packaging—they touch on the very science of how opioids interact with the human body.
Read the full article
About the author
334 episodes
Share
